Sientra increases sales but legal settlement doubles losses
Sientra increased net sales more than 30 percent for its second quarter ended June 30 but net losses doubled to $20.4 million, or $1.07 per share. The Goleta breast implant designer and manufacturer brought in $8.2 million in sales, up from $6.2 million for the second quarter of 2016, primarily for its breast products. Its Read More →
Mannkind reports net loss for second quarter
Mannkind reported $2.16 million in revenues Aug. 7, for a net loss of around $35.3 million for its second quarter, and announced the launch of a clinical trial for its inhalable insulin product Afrezza in partnership with One Drop. Revenues came primarily from the Westlake Village biotech company’s product sales, with $615,000 from collaborations and Read More →
Sienna stock still soaring after $65 million IPO
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Inogen net income up 11.3 percent for second quarter
Net income at Inogen rose 11.3 percent for the second quarter to $8.3 million, after a 17.5 percent bump in its revenues to $64.1 million. The Goleta-based portable oxygen concentrator maker sold 32,400 units during the quarter ended June 30, up nearly 30 percent from the same period in 2016. Earnings per share rose slightly Read More →
Sientra settles lawsuit with former manufacturer
Goleta-based breast implant manufacturer Sientra announced the settlement of an intellectual property and contract lawsuit with its former Brazilian manufacturer Silimed on Aug. 1. Securities and Exchange Commission documents filed by Sientra state that the two companies participated in court-ordered arbitration July 27, and Sientra agreed to pay $9 million within the next 30 days, Read More →
Amgen to pay $1.15 dividend to shareholders
The board of directors for Thousand Oaks biopharmaceutical giant Amgen approved at $1.15 dividend for the third quarter on July 28. Shareholders of record at the close of day on Aug. 17 will be paid the dividend on Sept. 8. • Contact Marissa Nall at mnall@pacbiztimes.com.
Amgen stock drops despite strong earnings
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
